ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, today ...

New Rate Determination Track at IPEC would aim to increase transparency and provide affordable benchmark rates for standard ...

ViiV & MPP extend voluntary licensing long-acting injectable HIV treatment, Indian pharma to benefit: Our Bureau, Bengaluru Tuesday, July 15, 2025, 12:45 Hrs [IST] ViiV Healthcare ...

Plaintiffs allege that CRISP and its subsidiary willfully infringed on patented technology by launching a copycat product after terminating a long-standing licensing agreement.

Sun recieved approval from the US Food and Drug Administration for Leqselvi in July 2024. Soon after the regulator’s approval ...

The Jumptuit Group (TJG) is an AI research and development company working in the emerging field of Anticipatory Intelligence ...

Newly issued U.S. patent extends certepetide IP protection to 2040, with subsequent opportunity for patent term extension ...

The European Commission has issued an informal guidance letter to provide antitrust guidance for the creation of a licensing negotiation group in the ...

Poised for Immediate Commercial Deployments and Licensing OpportunitiesCORNELIUS, N.C., July 09, 2025 (GLOBE NEWSWIRE) -- ...

The VDP Pool from AccessAdvance has successfully attracted a group of licensees/licensors including ByteDance, Kuaishou, NTT ...

Investing.com -- Ericsson (ST: ERICb) on Tuesday reported a net profit of SEK 4.6 billion in the second quarter of 2025, reversing a SEK 11 billion loss in the same period last year. The turnaround ...

The Delhi High Court has declined a plea moved by US-based Kroll Information Assurance, seeking to patent 'System to locate ...